Biological
Damoctocog alfa pegol clinical trials
Also written BAY94-9027.
- studies test it
- 5
- open now
- 0
- in phase 3
- 3
- first study started
- 2012
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
5 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2019 | 2 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 1
- Phase 3
- 3
- Phase 4
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses damoctocog alfa pegol is read from its arms, and is right about nine times in ten.
Testing it · 5
- A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the BloodCompletedPhase 3BayerNCT05147662Written as Damoctocog alfa pegol (Jivi, BAY94-9027)
- A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia ACompletedPhase 2/3BayerNCT01580293Written as BAY94-9027
- Study to Gain More Information on How Safe and Effective Jivi Works in Patients With Severe Hemophilia A (Post-marketing Investigation)CompletedPhase 4BayerNCT04085458Written as Damoctocog alfa pegol (Jivi, BAY94-9027)
- Study to Compare How the Body Distributes and Excretes the Drugs Jivi (BAY 94-9027) and Adynovi in Patients With Severe Hemophilia A (Bleeding Disorder Resulting From a Lack of Blood Clotting Factor VIII)CompletedPhase 1BayerNCT04015492Written as Damoctocog-alfa-pegol (BAY94-9027, Jivi)
- Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia ACompletedPhase 3BayerNCT01775618Written as BAY94-9027
Codes
What other systems call damoctocog alfa pegol · ClinicalTrials.gg INT016145
- UNII (FDA) BY4TSK952YDAMOCTOCOG ALFA PEGOLConfirmed FDA, Wikidata
- RxNorm 2055655Confirmed FDA, Wikidata
- Wikidata Q27274954damoctocog alfa pegolConfirmed FDA, Wikidata
- NCI Thesaurus C171718Damoctocog Alfa PegolOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | BY4TSK952Y | DAMOCTOCOG ALFA PEGOL | Confirmed FDA, Wikidata |
| RxNorm | 2055655 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27274954 | damoctocog alfa pegol | Confirmed FDA, Wikidata |
| NCI Thesaurus | C171718 | Damoctocog Alfa Pegol | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.